These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3923594)

  • 1. Cost-effectiveness of different strategies for prevention of congenital rubella infection: a practical example from Iceland.
    Gudnadóttir M
    Rev Infect Dis; 1985; 7 Suppl 1():S200-9. PubMed ID: 3923594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit-cost aspects of rubella immunization.
    Schoenbaum SC
    Rev Infect Dis; 1985; 7 Suppl 1():S210-1. PubMed ID: 3923595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass vaccination against rubella in Iceland after cost-benefit analysis].
    Olafsson O
    Nord Med; 1979 Sep; 94(8-9):203. PubMed ID: 113774
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefit-cost analysis of rubella vaccination policy.
    Schoenbaum SC; Hyde JN Jr Bartoshesky L; Crampton K
    N Engl J Med; 1976 Feb; 294(6):306-10. PubMed ID: 813141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of congenital rubella and results of rubella vaccination in Australia.
    Menser MA; Hudson JR; Murphy AM; Upfold LJ
    Rev Infect Dis; 1985; 7 Suppl 1():S37-41. PubMed ID: 3890106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of different vaccination programmes to prevent congenital rubella.
    Stray-Pedersen B
    NIPH Ann; 1982 Dec; 5(2):69-83. PubMed ID: 6820478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical aspects of rubella vaccination strategies.
    Knox EG
    Rev Infect Dis; 1985; 7 Suppl 1():S194-7. PubMed ID: 4001728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategies for the prevention of congenital rubella].
    Buekens P
    Rev Epidemiol Sante Publique; 1983; 31(3):283-8. PubMed ID: 6658102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of congenital rubella infection.
    Menser MA
    Med J Aust; 1984 May; 140(11):636-8. PubMed ID: 6425618
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of congenital rubella and congenital varicella in Europe.
    Pandolfi E; Chiaradia G; Moncada M; Rava L; Tozzi AE
    Euro Surveill; 2009 Mar; 14(9):16-20. PubMed ID: 19317971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females.
    Gudmundsdóttir S; Antonsdóttir A; Gudnadóttir S; Elefsen S; Einarsdóttir B; Olafsson O; Gudnadóttir M
    Bull World Health Organ; 1985; 63(1):83-92. PubMed ID: 3872738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination against rubella in Britain: benefits and risks.
    Freestone DS
    Dev Biol Stand; 1979; 43():339-48. PubMed ID: 520680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital rubella in the United Kingdom before 1970: the prevaccine era.
    Peckham C
    Rev Infect Dis; 1985; 7 Suppl 1():S11-6. PubMed ID: 4001719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting rubella for elimination.
    Taneja DK; Sharma P
    Indian J Public Health; 2012; 56(4):269-72. PubMed ID: 23354136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.
    Su SB; Guo HR
    Am J Trop Med Hyg; 2002 Nov; 67(5):549-53. PubMed ID: 12479561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM; Grenfell BT
    J Hyg (Lond); 1986 Apr; 96(2):305-33. PubMed ID: 3701044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of rubella and congenital rubella infection in Israel, a country with a selective immunization program.
    Swartz TA; Hornstein L; Epstein I
    Rev Infect Dis; 1985; 7 Suppl 1():S42-6. PubMed ID: 4001732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital rubella surveillance following epidemic rubella in a partially vaccinated community.
    Rachelefsky GS; Herrmann KL
    J Pediatr; 1974 Apr; 84(4):474-8. PubMed ID: 4834242
    [No Abstract]   [Full Text] [Related]  

  • 20. Developing rubella vaccination policy in Nepal--results from rubella surveillance and seroprevalence and congenital rubella syndrome studies.
    Upreti SR; Thapa K; Pradhan YV; Shakya G; Sapkota YD; Anand A; Taylor T; Mach O; Reef S; Pattamadilok S; Liyanage J; O'Connor P; Sedai T; Bhandary SR; Partridge J; Schluter W
    J Infect Dis; 2011 Jul; 204 Suppl 1():S433-8. PubMed ID: 21666196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.